HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary M Halliday Selected Research

Sunburn

2/2021Sex Differences in Photoprotective Responses to 1,25-Dihydroxyvitamin D3 in Mice Are Modulated by the Estrogen Receptor-β.
4/2015The alternative complement component factor B regulates UV-induced oedema, systemic suppression of contact and delayed hypersensitivity, and mast cell infiltration into the skin.
7/20131α,25-Dihydroxyvitamin D3 reduces several types of UV-induced DNA damage and contributes to photoprotection.
9/20111α,25(OH)₂-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis.
8/2010Topical calcitriol protects from UV-induced genetic damage but suppresses cutaneous immunity in humans.
2/2008UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide.
3/2007Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products.
10/2006Effect of topical melatonin on ultraviolet radiation-induced suppression of Mantoux reactions in humans.
8/2006[Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers.
10/2005Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary M Halliday Research Topics

Disease

30Skin Neoplasms (Skin Cancer)
02/2020 - 10/2002
15Neoplasms (Cancer)
02/2020 - 12/2002
12Carcinogenesis
12/2018 - 09/2008
10Sunburn
02/2021 - 10/2005
10Melanoma (Melanoma, Malignant)
02/2020 - 02/2004
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2018 - 04/2004
8Contact Dermatitis (Eczema, Contact)
02/2021 - 09/2002
8Erythema
08/2010 - 07/2003
7Inflammation (Inflammations)
02/2021 - 04/2005
6Actinic Keratosis
12/2018 - 05/2012
4Keratosis
01/2015 - 04/2004
3Hypersensitivity (Allergy)
01/2009 - 09/2002
2Basal Cell Carcinoma (Rodent Ulcer)
10/2015 - 05/2013
2Genomic Instability
01/2011 - 07/2010
1Lymphatic Metastasis
01/2020
1Cognitive Dysfunction
03/2019
1Hyperplasia
12/2018
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
04/2015
1Gout
03/2013
1Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
04/2012
1Neuroblastoma
02/2012
1Cockayne Syndrome (Syndrome, Cockayne)
09/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2010
1Pathologic Processes
09/2008
1Burns
08/2006
1Communicable Diseases (Infectious Diseases)
11/2004
1Human Influenza (Influenza)
02/2004

Drug/Important Bio-Agent (IBA)

14Niacinamide (Nicotinamide)FDA LinkGeneric
02/2020 - 01/2009
7Proteins (Proteins, Gene)FDA Link
12/2018 - 02/2004
6Pyrimidine DimersIBA
02/2021 - 08/2006
6DNA (Deoxyribonucleic Acid)IBA
12/2018 - 04/2005
4NickelIBA
09/2010 - 09/2002
4Sunscreening Agents (Sunscreens)IBA
02/2008 - 07/2003
3Vitamin DFDA LinkGeneric
02/2021 - 09/2011
3Calcitriol (Calcijex)FDA LinkGeneric
02/2021 - 03/2007
3ChromatinIBA
12/2018 - 04/2009
3CytokinesIBA
01/2018 - 02/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 04/2005
3Catalytic DNA (Deoxyribozyme)IBA
01/2018 - 06/2012
3Biological ProductsIBA
04/2015 - 04/2005
3Melanins (Melanin)IBA
08/2006 - 10/2003
2hydroxide ionIBA
02/2021 - 09/2011
2Hormones (Hormone)IBA
02/2021 - 08/2006
2AntibodiesIBA
01/2018 - 06/2012
2Adenosine Triphosphate (ATP)IBA
04/2014 - 01/2013
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2013 - 04/2005
2Messenger RNA (mRNA)IBA
06/2012 - 06/2012
28-Hydroxy-2'-DeoxyguanosineIBA
05/2012 - 09/2011
2Tuberculin (PPD)IBA
01/2009 - 11/2004
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1cyclo(Arg-Pro) (CI 4)IBA
10/2015
125-hydroxyvitamin DIBA
04/2015
1Complement System Proteins (Complement)IBA
04/2015
1Complement Factor B (Factor B)IBA
04/2015
1Calcitriol Receptors (Calcitriol Receptor)IBA
04/2015
1ArsenicIBA
01/2015
1LipidsIBA
01/2015
1VitaminsIBA
07/2014
1ChemokinesIBA
04/2014
1plerixaforFDA Link
04/2014
1Transcription Factors (Transcription Factor)IBA
05/2013
1Dz13 DNAzymeIBA
05/2013
1Allopurinol (Remid)FDA LinkGeneric
03/2013
1Uric Acid (Urate)IBA
03/2013
1Pharmaceutical PreparationsIBA
03/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2012
1LigandsIBA
04/2012
1RetinoidsIBA
02/2012
1Tripartite Motif ProteinsIBA
02/2012
1DNA Repair EnzymesIBA
12/2011
18-hydroxyguanineIBA
09/2011
1MicroRNAs (MicroRNA)IBA
09/2011
1Interleukin-33IBA
07/2011
11-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2011
1Nucleosomes (Nucleosome)IBA
01/2011
1calcipotriene (calcipotriol)FDA LinkGeneric
08/2010
1NAD (NADH)IBA
07/2010
1HaptensIBA
01/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2008
1Transforming Growth Factor beta (TGF-beta)IBA
01/2008
1tyramine-deoxysorbitolIBA
03/2007
1MelatoninIBA
10/2006
1alpha-MSHIBA
08/2006
1Melanocyte-Stimulating Hormones (MSH)IBA
08/2006
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2005
1ProstaglandinsIBA
04/2005
14',7-dihydroxy-3,4-dihydroisoflavoneIBA
11/2004
1xyloglucanIBA
11/2004
1VaccinesIBA
02/2004
1AntigensIBA
02/2004

Therapy/Procedure

10Chemoprevention
02/2020 - 01/2013
4Immunotherapy
01/2020 - 12/2002
3Therapeutics
01/2018 - 02/2012
2Lasers (Laser)
01/2005 - 04/2004
2Immunomodulation
11/2004 - 10/2002
1Withholding Treatment
01/2018
1Photochemotherapy (Photodynamic Therapy)
04/2011
1Subcutaneous Injections
08/2006